IMDX
Insight Molecular Diagnostics Inc. Common Stock
IMDX
IMDX
95 hedge funds and large institutions have $201M invested in Insight Molecular Diagnostics Inc. Common Stock in 2021 Q3 according to their latest regulatory filings, with 17 funds opening new positions, 37 increasing their positions, 28 reducing their positions, and 11 closing their positions.
Holders
95
Holders Change
+5
Holders Change %
+5.56%
% of All Funds
1.67%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.04%
New
17
Increased
37
Reduced
28
Closed
11
Calls
$1.28M
Puts
$178K
Net Calls
+$1.1M
Net Calls Change
+$402K
Top Buyers
| 1 |
O
1
OrbiMed
New York
|
$10.2M |
| 2 |
DC
2
Defender Capital
Charlotte,
North Carolina
|
$6.94M |
| 3 |
BC
3
Broadwood Capital
New York
|
$61.8M |
| 4 |
MAG
4
Millrace Asset Group
Berwyn,
Pennsylvania
|
$2.19M |
| 5 |
5
D.E. Shaw & Co
New York
|
$729K |
Top Sellers
| Name | Holding | Trade Value |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
|
MLICM
101
Metropolitan Life Insurance Company (MetLife)
New York
| – | -$133K | -1,162 | Closed |
|
|
PCM
102
Pinz Capital Management
New York
| – | -$125K | -1,085 | Closed |
|
103
ProShare Advisors
Bethesda,
Maryland
| – | -$106K | -919 | Closed |
|
|
CSS
104
Cubist Systematic Strategies
Stamford,
Connecticut
| – | -$77K | -670 | Closed |
|
|
S
105
SignatureFD
Atlanta,
Georgia
| – | -$1K | -6 | Closed |
|